Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: A mixed methods study
Lisa M. Wu, Molly L. Tanenbaum, Marcel Dijkers, et al.
Social Science & Medicine (2016) Vol. 156, pp. 80-89
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Impact of Testosterone on Alzheimer’s Disease
Vittorio Emanuele Bianchi
The World Journal of Men s Health (2022) Vol. 40, Iss. 2, pp. 243-243
Open Access | Times Cited: 44
International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients
Sabine Deprez, Shelli R. Kesler, Andrew J. Saykin, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 3, pp. 223-231
Open Access | Times Cited: 84
Androgen Regulation of the Mesocorticolimbic System and Executive Function
Daniel J. Tobiansky, Kathryn G. Wallin-Miller, Stan Floresco, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 78
A review of prostate cancer treatment impact on the CNS and cognitive function
Charles J. Ryan, Jeffrey S. Wefel, Alicia K. Morgans
Prostate Cancer and Prostatic Diseases (2019) Vol. 23, Iss. 2, pp. 207-219
Open Access | Times Cited: 75
Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer
Farzin Khosrow‐Khavar, Soham Rej, Hui Yin, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 2, pp. 201-207
Closed Access | Times Cited: 64
An Updated Review: Androgens and Cognitive Impairment in Older Men
Zhonglin Cai, Hongjun Li
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 47
Circadian disruption and cancer- and treatment-related symptoms
Ali Amidi, Lisa M. Wu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 25
Understanding neurocognitive recovery in older adults after total hip arthroplasty—neurocognitive assessment, blood biomarkers and patient experiences: a mixed-methods study
Anahita Amirpour, Lina Bergman, Gabriela Markovic, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e093872-e093872
Open Access
Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients
Lisa M. Wu, Ali Amidi
Current Opinion in Supportive and Palliative Care (2016) Vol. 11, Iss. 1, pp. 38-45
Open Access | Times Cited: 40
Obesity and Cancer: Excess Body Fat as a Risk Factor in Carcinogenesis; Consequences Across Human Body Systems and Significance for Associated Medical Specialties
Nicholas A Kerna, Taylor M. Nicely, Uwakmfonabasi Umoudoh, et al.
European Journal of Medical and Health Research (2025) Vol. 3, Iss. 2, pp. 122-135
Closed Access
Cognitive Effects of Androgen Deprivation Therapy in Men With Advanced Prostate Cancer
Bülent Günlüsoy, Yasin Ceylan, Aslı Köşkderelioğlu, et al.
Urology (2017) Vol. 103, pp. 167-172
Closed Access | Times Cited: 38
Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study
Lisa M. Wu, Ali Amidi, Molly L. Tanenbaum, et al.
Supportive Care in Cancer (2017) Vol. 26, Iss. 6, pp. 1917-1926
Open Access | Times Cited: 38
Impact of androgen deprivation therapy on mood, cognition, and risk for AD
Monique M. Cherrier, Celestia S. Higano
Urologic Oncology Seminars and Original Investigations (2019) Vol. 38, Iss. 2, pp. 53-61
Open Access | Times Cited: 32
Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Jonathan Kluger, Alicia Roy, Herta H. Chao
Current Oncology Reports (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 30
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
Fabio Turco, Lavinia Di Prima, Chiara Pisano, et al.
Research and Reports in Urology (2023) Vol. Volume 15, pp. 9-26
Open Access | Times Cited: 10
Efficacy of a hypnosis-based intervention to improve well-being during cancer: a comparison between prostate and breast cancer patients
Charlotte Grégoire, H. Nicolas, Isabelle Bragard, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 30
Cervical cancer survivors’ perceived cognitive complaints and supportive care needs in mainland China: a qualitative study
Yingchun Zeng, Andy S. K. Cheng, Xiangyu Liu, et al.
BMJ Open (2017) Vol. 7, Iss. 6, pp. e014078-e014078
Open Access | Times Cited: 29
<p>Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment</p>
Piotr Jarzemski, Bartosz Brzoszczyk, Alicja Popiołek, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 819-829
Open Access | Times Cited: 24
Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies
Andrea Kokorovic, Alan So, Hosam Serag, et al.
Canadian Urological Association Journal (2021) Vol. 15, Iss. 6
Open Access | Times Cited: 18
Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe
Charlotte Sleurs, Ali Amidi, Lisa M. Wu, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103859-103859
Open Access | Times Cited: 13
Giftedness and atypical sexual differentiation: enhanced perceptual functioning through estrogen deficiency instead of androgen excess
Kikue Sakaguchi, Shintaro Tawata
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Androgen deprivation exacerbates AD pathology by promoting the loss of microglia in an age-dependent manner
Jia-Xin Cao, Haichao Chen, Yishu Zhang, et al.
Life Sciences (2024) Vol. 355, pp. 122973-122973
Closed Access | Times Cited: 2
Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15‐month prospective, observational study
Zhiqiang Zhang, Linlin Yang, Dongdong Xie, et al.
Psycho-Oncology (2017) Vol. 26, Iss. 12, pp. 2238-2244
Closed Access | Times Cited: 17
Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors
Jeffrey S. Wefel, Charles J. Ryan, Julie Van, et al.
CNS Drugs (2022) Vol. 36, Iss. 5, pp. 419-449
Open Access | Times Cited: 9
UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text)
Andrea Kokorovic, Alan So, Hosam Serag, et al.
Canadian Urological Association Journal (2022) Vol. 16, Iss. 8, pp. E416-31
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top